These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33327276)

  • 1. Prevalence and management of hypercholesterolemia in France, the Esteban observational study.
    Blacher J; Gabet A; Vallée A; Ferrières J; Bruckert E; Farnier M; Olié V
    Medicine (Baltimore); 2020 Dec; 99(50):e23445. PubMed ID: 33327276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia, eligibility for lipid-lowering therapy and therapeutic success: population-based study in a Portuguese urban population.
    Alves L; Azevedo A
    Eur J Endocrinol; 2008 Dec; 159(6):755-60. PubMed ID: 18796541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg.
    Lee YH; Lee SG; Lee MH; Kim JH; Lee BW; Kang ES; Lee HC; Cha BS
    J Am Heart Assoc; 2014 Feb; 3(1):e000650. PubMed ID: 24572249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients.
    Béliard S; Millier A; Carreau V; Carrié A; Moulin P; Fredenrich A; Farnier M; Luc G; Rosenbaum D; Toumi M; Bruckert E;
    J Clin Lipidol; 2016; 10(5):1129-1136.e3. PubMed ID: 27678429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
    Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
    Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E; Salvetti M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of hypertension management in France in 2015: The ESTEBAN survey.
    Vallée A; Gabet A; Grave C; Sorbets E; Blacher J; Olié V
    J Clin Hypertens (Greenwich); 2020 Apr; 22(4):663-672. PubMed ID: 32092238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Pediatric and Adult Guidelines for Treatment of Lipid Levels Among US Adolescents Transitioning to Young Adulthood.
    Gooding HC; Rodday AM; Wong JB; Gillman MW; Lloyd-Jones DM; Leslie LK; de Ferranti SD
    JAMA Pediatr; 2015 Jun; 169(6):569-74. PubMed ID: 25845026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaps in Dyslipidemia Care Among Working-Aged Individuals With Employer-Sponsored Health Care.
    Shiffman D; Louie JZ; Devlin JJ; Knowles JW; McPhaul MJ
    J Am Heart Assoc; 2020 May; 9(9):e015807. PubMed ID: 32319337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis.
    Barkas F; Nomikos T; Liberopoulos E; Panagiotakos D
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic.
    Kiburg KV; Ward GM; O'Neal DN; MacIsaac RJ
    Intern Med J; 2018 Feb; 48(2):201-204. PubMed ID: 29415350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic management of South African dyslipidaemic patients at very high cardiovascular risk (CARDIO TRACK): a cross-sectional study.
    Blom DJ; Ranjith N; Joshi P; Naidoo P; van Tonder A; Musa MG; Joshi S; Leisegang R; Trokis JS; Makan H; Raal FJ
    Cardiovasc J Afr; 2020; 31(5):245-251. PubMed ID: 33151240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undertreatment of hypercholesterolemia.
    Daskalopoulou SS; Doonan RJ; Mikhailidis DP
    Curr Med Res Opin; 2010 Feb; 26(2):439-43. PubMed ID: 20001650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring and treating serum lipids in patients in a chest pain observation unit.
    Gillespie MJ; Davis CJ; Lambert ND; Costello FM; Smith SC; Cohen MG; Menon V
    Am J Cardiol; 2007 Jun; 99(12):1718-20. PubMed ID: 17560881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Cholesterol Treatment Eligibility and Medication Use Among Adults--United States, 2005-2012.
    Mercado C; DeSimone AK; Odom E; Gillespie C; Ayala C; Loustalot F
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1305-11. PubMed ID: 26633047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, awareness, treatment, and control of high LDL cholesterol in New York City, 2004.
    Upadhyay UD; Waddell EN; Young S; Kerker BD; Berger M; Matte T; Angell SY
    Prev Chronic Dis; 2010 May; 7(3):A61. PubMed ID: 20394700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid attainment among patients newly treated with lipid-altering drugs.
    Hess G; Chang CL; Chung K
    Curr Med Res Opin; 2014 Sep; 30(9):1743-56. PubMed ID: 24889282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.